Fosun Group is on course to plant a new marker for Hong Kong’s equity markets following the launch of an initial public offering in Sisram Medical this Thursday.
The IPO, which will raise up to HK$1.35 billion $174 million, is the first example of a Chinese company listing one of its offshore assets back home. It will also represent the first Israeli company to list in Hong Kong.
Sisram Medical is a special purpose vehicle established in 2013 after Fosun’s $240 million acquisition of Alma Lasers, an Israel-based developer of laser devices for aesthetic and medical use.
As...